Chemical Structure (Xadago 01)
Xadago Tablet, Film Coated
Product Images NDC 27505-110
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Xadago (NDC 27505-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mdd Us Operations Llc, A Subsidiary Of Supernus Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Xadago 02)
Figure 2 (Xadago 03)
The text describes a table or a graph showing "Cumulative Percentage" and "Change from Baseline to Week 24 in total Daily "ON" Time (hours)." It also shows the labels "Placebo" and "XADAGO 50 mg/day —XADAGO 100 mg/day." The rest of the text appears to be placeholders for numeric values or labels. No further information can be gleaned from this text.*
Figure 3 (Xadago 04)
Figure 4 (Xadago 05)
This is a table showing the change in total daily "ON" time (hours) for patients receiving either a placebo or XADAGO 50-100 mg/day from baseline to week 24. The table also includes the cumulative percentage (%) of patients who experienced a decrease or increase in ON time.*
Principal Display Panel (50 mg Tablet Bottle Carton)
This is a product description for Safinamide tablets with a registered trademark Xadago®. Each bottle contains 50mg of Safinamide. It is manufactured by Zambon SpA and distributed by US WorldMeds, LLC. The tablets should be stored at 25°C with excursions permitted between 15°C to 30°C. More information and full prescribing details are available in the package insert. The product comes with a LOT number and a serial number.*
Principal Display Panel (100 mg Tablet Bottle Carton)
This text is a description of a medication called Xadago, which contains 100mg of Safinamide to treat Parkinson's disease. The medication should be stored at a controlled room temperature and comes in a container with 30 tablets. The text also includes the contact information of the distributor, US WorldMeds, LLC, and the manufacturer, Zambon SpA.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
